IND filing and initial clinical data on first targeted Radio-DARPin therapy program, MP0712, expected in 2025; strategic partnership with Orano Med expanded from four to ten programs "Molecular ...

A revolutionary new beauty buy that promises to transform your neck and chest in a matter of weeks has left an Australian ...

Initiated dosing of participants in the first-in-human study of ABS-101 (anti-TL1A antibody), with interim data expected in the second half of 2025 ABS-201 (anti-PRLR) non-human primate (NHP) data ...

A new study suggests that people who are at risk for rare genetic forms of frontotemporal dementia should consider being ...

Melbourne’s Peter MacCallum Cancer Centre – aka Peter Mac – is Australia’s only public hospital dedicated to cancer care, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

When it comes to contraception, the burden has largely fallen on women to take responsibility – whether that be by taking the pill, getting the implant or having an IUD inserted.  All of which, of ...

A new type of tobacco product has seen rising use around the world, but there are still serious questions about how it ...

"As we've said before, trials from four years ago conducted in people without natural immunity no longer suffice. A four-year ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about ...

Section Head, Cancer Medicine, Clinical Research Division Fred Hutchinson Cancer Center Medical Director, Clinical Research Support Fred Hutchinson Cancer Research Consortium Professor of Medicine ...

Professor Ian White, MRC Clinical Trials Unit at UCL Dr Tim Morris, MRC Clinical Trials Unit at UCL, London Dr Matteo Quartagno, MRC Clinical Trials Unit at UCL, London Dr Tra My Pham, MRC Clinical ...